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Benflurone is an original Czechoslovak cytostatic drug developed at Research Institute 
of Pharmacy and Biochemistry (VÚFB). Due to its unfavorable pharmacokinetic properties it 
has not been used for human therapy of cancer. Dimeflurone, developed with aim to improve 
pharmacokinetics of benflurone, was discontinued either at the phase of preclinical trials. 
Disadvantageous properties of both drugs is caused by rapid deactivation leading to formation 
of nearly inactive 7-hydroxyderivatives. 
In my diploma thesis, I concern about synthesis, in vivo and in vitro biological 
evaluation of C7-derivatives of both compounds. We assume lower deactivation rate and also 
longer and more potent effect. Firstly, sufficient amount of dimeflurone had to be synthesized, 
this process was improved and scaled-up. 
Although all the derivatives are more cytotoxic on cell lines MCF-7, BT-549 and 
MDA-MB-231 and they are also less toxic in mice after p.o. administration, they do not 
reduce weight of solid Ehrlich tumor neither prolong time of survival. 
